New Research Areas Dsa
The identification clinically useful analgesic targeting nonopioid mechanisms has been challenging as demonstrated by the failure of several novel tachykinin NK-1 receptor antagonists in clinical trials.39 Other novel analgesic agents have either not been advanced or are used in only limited conditions due to mechanism related toxicities. For example, the analgesic efficacy of ziconotide, a selective neuronal calcium channel N-type, Cav2.2 blocker discussed in more detail below is limited to...
Unmet Medical Needs Rno
Due to the relatively poor efficacy to tolerability ratio for opioid analgesics in treating neuropathic pain, this area represents a major unmet medical need. While gabapentin and other adjuvant analgesics have been reported to be clinically effective in treating neuropathic pain, the efficacy rates are relatively small and are often accompanied by side effects of sufficient magnitude to limit compliance.7 This situation is not surprising in that essentially all clinically used analgesic...
Overview and Comparison of Drug Classes
Historically the treatment of ADHD relied on agents affecting monoaminergic neurotransmission, and largely consisted of the stimulants, antidepressants, and antihypertensive agents Table 1 .1'65 The primary pharmacological treatment for ADHD continues to be the use of stimulants, particularly methylphenidate and amphetamines. Methylphenidate has long been the leading treatment for ADHD however it has a short duration of action and a midday dose is required. In schoolchildren, this necessitates...
Info Ihe
6.06.4.4 Breathing-Related Sleep Disorder 152 6.06.4.5 The SCORE System 152 6.06.4.6 Transgenic Models and Sleep 152 6.06.5 Clinical Trial Issues 153 6.06.5.1 Narcolepsy and Primary Hypersomnia 153 6.06.5.2 Primary Insomnia 153 6.06.5.3 Circadian Rhythm Sleep Disorder 153 6.06.6 Current Treatment 153 6.06.6.1 Narcolepsy and Primary Hypersomnia 153 6.06.6.2 Amphetamine-Like Stimulants 155 6.06.6.2.1 Methylphenidate and dexmethylphenidate 155 6.06.6.2.2 Pemoline and selegiline 155 6.06.6.2.3...
Fibrates as highdensity lipoprotein cholesterolelevating agents
Several clinical studies have demonstrated that a reduction in CHD events is positively correlated with treatments that raised HDLc. The controlled Helsinki Heart Trial monitored coronary event rates in over 4000 asymptomatic middle-aged males with dyslipidemia for 5 years and showed that correcting low levels of HDLc with gemfibrozil led to a 34 decrease in coronary events.4'57 For each 1 mg dL _ 1 rise in HDLc among the study subjects, the average response was a 3 decrease in CHD risk....
New Research Areas Skb
Serotonin 5HT1B 1D receptor agonists, the triptans 7, and related 5HT receptor agonists, 9, 10, provided the most important advance in migraine therapeutics in the four millennia that the condition has been recognized. Simultaneously the development of triptans, with their vasoconstrictor action, produced a small clinical penalty in terms of coronary vasoconstriction and an enormous intellectual question the extent to which migraine is a vascular problem. Functional neuroimaging and...
Neurorestorative Drug Discovery
Until a decade ago, it was firmly believed that once the brain or spinal cord was damaged by the acute and subacute secondary injury process there was little, if any, capability for regeneration of axons or the formation of new synapses. However, over the last several years it has been discovered that CNS neurons are indeed capable of significant structural and functional regeneration and repair. These processes might be pharmacologically enhanced, either by reawakening the growth potential of...
Models of Acute Pain
Animal models of acute pain allow the evaluation of the effects of potential analgesics on pain sensation transmission in an otherwise normal animal. In addition, the same tests may be used to measure stimulus-evoked pain in animals with chronic inflammation or nerve injury. Usually, these tests rely on an escape behavior withdrawal reflex or vocalization as an index of pain. The animals have control over the duration of the pain, that is, their behavioral response leads to termination of the...
Info Wow
6.19.1.2 Impact of High Prevalence of Diabetes, Obesity, and the Metabolic Syndrome 6.19.1.2.1 Cardiovascular disease Obese individuals have a two-fold increase in all-cause mortality compared with normal-weight individuals, with the largest increased risk being in cardiovascular mortality. Similarly, individuals with diabetes have a twofold increase in all-cause mortality compared with non-diabetics8 and life expectancy is reduced by approximately 10 years. Cardiovascular disease CVD is the...
yAminobutyric acid receptor antagonists
GABA, the major inhibitory neurotransmitter in the CNS, acts via GABAa, GABAb, and putative GABAc receptors. GABAa and GABAc receptors are ligand-gated ion channels, while GABAB receptors are 7TM-GPCRs. The GABAb receptor is of most interest as a target for AD. Both autoreceptors and heteroreceptors exist for the GABAb receptor family that modulate the presynaptic release of GABA as well as glutamate, various monoamines, and neuropeptides. GABA receptor activation inhibits learning thus...
Scn
Brainstem Ascending cortical activation REM SWS switch Figure 2 Systems regulating sleep-wake biology. Upper panel a Sleep-wake states are controlled through a delicate balance of activities between the thalamus cortical activation and EEG synchronization , the hypothalamus sleep wake switch , the superchiasmatic nucleus SCN or circadian clock and the brainstem ascending cortical activation, REM SWS switch . Lower panel b Multiple neurotransmitters are involved in sleep-wake regulation. The...
Animal Models of Depression
Animal models of depression26-28 and BPAD have proved to be of considerable value in elucidating basic pathophysiological mechanisms and in developing novel treatments. However, the challenges faced by psychopharma-cologists in modeling human affective disorders in experimental animals are fraught with difficulties. As new targets emerge through hypothesis-driven research or serendipity, the challenge is to link the mechanism to a clinical complex and heterogeneous disorder. Consequently, much...
Selective serotonin reuptake inhibitors SSRIs
While the primary mode of action of TCAs was thought to be inhibition of NE reuptake, a reassessment of the actions of the diverse antihistamines on the reuptake of various biogenic amines, especially 5HT, led to the hypothesis that an increase in brain noradrenergic function caused the energizing and motor stimulating effects of the TCAs, but that an increase in 5HT function was responsible for their mood-elevating effects.42 Structural analogs of diphenhydramine were sought as novel...
Neurodegeneration
D Bozyczko-Coyne and M Williams, Worldwide Discovery Research, Cephalon, Inc., West Chester, PA, USA 2007 Elsevier Ltd. All Rights Reserved. 6.08.2 Alzheimer's Disease 196 6.08.2.1 Disease State Diagnosis 196 6.08.2.2 Disease Basis 197 6.08.2.2.1 The cholinergic hypothesis 198 6.08.2.2.2 The amyloid hypothesis 198 6.08.2.2.3 The tau hypothesis 198 6.08.2.2.4 The inflammatory cascade hypothesis 198 6.08.2.2.5 Genetic risk factors 198 6.08.2.3 Experimental Disease Models 199 6.08.2.3.1...
Vesicular neurotransmitter transporters VMATs and neurotransmitter transporters
Neurotransmitters are synthesized in neurons and concentrated in vesicles for their subsequent Ca2 -dependent release into the synaptic cleft, where they are inactivated by either enzymatic degradation or active transport in neuronal and or glial cells by neurotransmitter transporters.17 Molecular cloning has allowed the pharmacological and structural characterization of a large family of related genes encoding Na Cl_-dependent neurotransmitter transporters SCDNTs . The identification of a...
Im Ai
HMG-CoA reduccase inhibicor scacin HMG-CoA reduccase inhibicor scacin HMG-CoA reduccase inhibicor scacin 2-Morpholinoechyl escer of mycophenolic acid prodrug 2- Bis 2-chloroechy 1 amino cecrahydro-2 -13,2-oxazaphosphorine 2-oxide monohydrace prodrug Imidazolyl derivacive of 6-mercapcopurine N - 4- 2,4-Diamino-6-pceridinyl mechyl mechyl-amino benzoyl -L-glucamic acid ai -Bucylamino mechyl -4-hydroxy-w-xylene-a,a'-diol sulface 3-Hydroxy- 1-mechylpyridinium bromide dimechylcarbamace...
Ch3 1
Caffeine, 1, the most widely used natural psychostimulant can combat drowsiness, fatigue and impaired alertness but has limited efficacy and tolerates with excessive use which also causes withdrawal headache. Concerns regarding abuse liability and cardiovascular side effects limit the use of stimulants.62 Agents currently approved for use in the treatment of narcolepsy and hypersomnia are shown in Table 2. Two new drugs, modafinil, 11, and sodium oxybate g-hydroxybutyric acid, GHB, 12 have been...
Jnj17216498
6.06.6.2 Amphetamine-Like Stimulants Amphetamines including mixed salts have long been first line therapy of hypersomnolence and narcolepsy.64 Amphetamine is a central stimulant that promotes the release of DA, NE, and 5HT. Their primary effects are mediated through reverse efflux of DA via inhibition of the DAT. At higher doses, inhibition of vesicular monoamine transporter VMAT which is involved in amine storage enhances stimulant pharmacology, increasing amine quantities available for...
Trace Amines
In addition to the classical monoamines NE, 5HT, and DA, there exists a class of 'trace amines' that are found in very low levels in mammalian tissues, and include tyramine, b-phenylethylamine b-PEA , tryptamine, and octopamine.74 The rapid turnover of trace amines, as evidenced by the dramatic increases in their levels following treatment with MAOIs or deletion of the MAO genes, suggests that the levels of trace amines at neuronal synapses may be considerably higher than predicted by...
GABAa subtypeselective benzodiazepine site ligands
No NCEs have yet been reported with a high degree of selective affinity for GABAA receptor subtypes believed to be important for anxiolysis. However, compounds have been identified that, despite having similar affinities, show a degree of functional selectivity for different a-subunit-containing GABAA receptors i.e., they behave as full or partial modulators of certain subtypes and neutral modulators of others . A compound preferentially potentiating a2-subunit-containing GABAA receptor...
The Serotonin 5HT Hypothesis
The serotonin 5HT hypothesis of schizophrenia actually pre-dates that of DA. The ability of the hallucinogen lysergic acid diethylamide LSD to antagonize the effects of 5HT on smooth muscle led to the hypothesis that schizophrenia was caused by a decrease in central serotonergic function.11 This theory, largely predicated on the similarities between schizophrenic psychosis and LSD-induced hallucination, was modified with the discovery that LSD could act as a 5HT agonist in some systems. These...
The Glutamate Hypofunction Hypothesis
Glutamate is the major excitatory neurotransmitter in the CNS, and antagonists of the NMDA N-methyl-D-aspartate subtype of glutamate receptor, the psychotomimetics, phencyclidine 2 PCP and ketamine 3, mimic the positive, negative, and cognitive symptoms of schizophrenia.13 In the clinic, NMDA receptor antagonists faithfully mimic the symptoms of schizophrenia to the extent that it is difficult to differentiate the two. Controlled human studies of psychosis induced by the NMDA receptor...
The monoamine theory
The monoamine theory of depression and drugs acting on monoamine neurotransmission has dominated the treatment of depression for over 30 years. Indeed, the monoamine reuptake inhibitors and the MAOIs were shown to have antidepressant activity by chance, and the discoveries of their modes of action were instrumental in developing the monoamine theory. In the days when the monoamine theory of depression was evolving, the focus was more on norepinephrine NE than 5HTor dopamine DA . The theory...
Biographies 1
Michael J Marino, PhD, received his PhD in 1995 from the University of Pittsburgh Department of Neuroscience where he employed behavioral and electrophysiological methods to the study of G-proteins and G-protein coupled receptors. As a postdoctoral fellow with Dr Jeff Conn at Emory University, he performed pioneering work on the role of metabotropic glutamate receptors in regulating the circuitry of the basal ganglia. This work led to the identification of potential targets for the treatment of...
Psychiatric Disorders 601411 Schizophrenia
Schizophrenia see 6.02 Schizophrenia is a complex and debilitating neurodevelopmental psychiatric disorder that affects approximately 1 of the population. It is characterized by diminished drive and emotion during childhood followed by a deviation from reality with hallucinations, and appears to have both genetic and epigenetic causality. Schizophrenia presents with a spectrum of positive, negative, and cognitive symptoms. Positive symptoms include auditory and visual hallucinations, delusions,...